It's logical to try untested drugs when someone is going to
It's logical to try untested drugs when someone is going to die without it.
I think that remdesivir is promising. There was a guy who was in the Omaha isolation group (from that first cruise ship) that got remdesivir, and he wrote an article about how he felt tremendously better after his first dose. Again, it's just anecdotal. Studies of anti-viral drugs are needed not just for this emergency, but for the next horrible disease that jumps from animal to human.
If the West is serious about stopping these kinds of pandemics, they need to pressure China and Thailand to STOP having those so-called "wet markets" that have animals housed in tiny cages next to each other, and slaughter those animals right there in horribly unsanitary conditions.
If you want to sicken yourself, find the 60 Minutes Australia YouTube about wet markets. I'm sorry, I don't remember who first posted it here.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...
Continue Reading
Two trophies in Novi do not fill an order book, but Marelli’s latest pair says something useful about where automotive suppliers are trying to earn their keep. The company collected a 2026 Automotive News PACE Award for HorizonView and a PACE Pilot Award for Affordable 5G RedCap at the November 17 ceremony. One is already deployed in production; the other is a...
Continue Reading
Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...
Continue Reading
A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...
Continue Reading
Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...
Continue Reading
A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...
Continue Reading
Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...
Continue Reading
Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...
Continue Reading
Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...
Continue Reading
Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...
Continue Reading
Top 5 Most Recently Viewed Articles
Unisys to Connect with Investors at Sidoti Conference Soon Unisys (NYSE: UIS), a leader in technology solutions, is preparing to participate in the upcoming Sidoti Small-Cap Conference. This virtual event allows investors to hear directly from the company's executives, offering valuable insights. Meet with Unisys Executives The conference provides a fantastic chance for...
Continue Reading
VedaBio, a key player in biotechnology, took a bold step back in 2024 by appointing Randy Rasmussen, Ph.D., to its Board of Directors. This wasn’t just a casual hire; it’s an infusion of over 30 years of expertise into their operation. With Dr. Rasmussen at the helm, the chatter on the trading floor picked up—everyone was eyeing how this could reshape VedaBio's...
Continue Reading
Acuity Brands to Release Fiscal 2025 First-Quarter Results Acuity Brands, Inc. (NYSE: AYI) has announced an important date for investors and stakeholders. The company will release its fiscal 2025 first-quarter results on a Thursday morning, signaling its ongoing commitment to transparency and communication with its shareholders. Details of the Upcoming Announcement The...
Continue Reading
NV5 Global Secures Stockholder Approval for Merger with Acuren Recently, NV5 Global, Inc. (NASDAQ: NVEE), a prominent provider of technology-driven engineering, testing, inspection, and consulting services, announced a major milestone. A significant majority of its stockholders voted in favor of the merger with Acuren Corporation, showcasing strong support for this...
Continue Reading
Understanding the New EU USB-C Directive The recent implementation of the EU’s USB-C directive has stirred discussions among electronics users, particularly MacBook owners. Effective from 2025, this directive mandates that mobile devices, including smartphones and tablets, must incorporate a USB-C port for charging. The significance of this directive extends beyond just...
Continue Reading